Crowdonomics
All companies
Revero logo

Revero

Operating

Revero Inc

Healthcare · Technology · San Francisco, CA · Founded 2019

Visit website

Reversing autoimmune and other chronic diseases by addressing the root causes

Valuation cap ⓘ
$50.0M
As of Dec 2025 · from Reg CF Offering (2025) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$4,275,768
Across 2 rounds since 2022

Financials

FY2019–FY2025 · from SEC filings · hover any figure for its source
$39K
$37K
2019
$590K
$338K
2020
$567K
$68K
2021
$529K
−$405K
2022
$409K
$2.1M
2023
$505K
$251K
2024
$1.0M
$2.1M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$39,260
$589,658
$567,347
$529,087
$408,661
$504,503
$1,040,267
Cost of goods sold
$540
$12,301
$16,822
$29,975
$65,684
$137,468
$822,423
Gross margin
99%
98%
97%
94%
84%
73%
21%
Net income
$37,217
$338,410
$67,713
-$405,131
$2,062,404
$250,643
$2,124,414
Taxes paid
$0
$0
$96,520
$21,613
$0
$800
$6,040
Balance sheet
Cash
$37,297
$441,519
$479,048
$4,910,541
$2,936,450
$2,624,576
$2,278,956
Accounts receivable
$0
$0
$0
$0
$0
$0
$0
Total assets
$37,297
$446,730
$519,433
$5,001,845
$3,047,680
$2,697,732
$2,330,997
Short-term debt
$0
$71,024
$4,241
$11,902
$104,905
$118,198
$136,403
Long-term debt
$0
$0
$0
$4,879,882
$1,003,590
$890,992
$8,057,476
Total liabilities
$0
$71,024
$4,241
$4,891,784
$1,108,495
$1,009,190
$8,193,879
Other
Headcount
—
2
3
5
—
5
6

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$30.0M
Valuation cap
$50.0M
Valuation cap
Revero Crowd SAFE 1
Reg CF Offering (2025)

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Reg CF Offering (2025)ClosedReg CF · SAFE · via Republic
Raised $1.3M / $1.5MInvestors 844Valuation cap $50M
Revero Crowd SAFE 1ClosedReg CF · SAFE · via Republic
Raised $3M / $3MInvestors 3,074Valuation cap $30M

Team

2 people
Mahsa Rostami
Chief Executive Officer
Shawn Baker
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 3 of 5 annual reports (FY2021–FY2025)

3,074 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 10 filings on EDGAR
  • Form C-ARMay 1, 20260001878261-26-000001
    EDGAR
  • Form C-UDec 29, 20250001878261-25-000004
    EDGAR
  • Form CSep 24, 20250001878261-25-000003
    EDGAR
  • Form C-ARMar 22, 20230001943286-23-000003
    EDGAR
  • Form C-TRMar 22, 20230001943286-23-000004
    EDGAR
  • Form C-ARApr 27, 20220001878261-22-000002
    EDGAR
  • Form C-UApr 19, 20220001910977-22-000004
    EDGAR
  • Form C/AMar 28, 20220001879376-22-000004
    EDGAR
Source: ManualCIK 0001878261DE

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.